Medical cannabis to be trialled in treatment of melanoma at the University of Canberra

Scientists in Canberra will develop a new treatment for skin cancer using medicinal-grade cannabis, with clinical trials to begin in the ACT next year.

The University of Canberra has signed a million-dollar deal with Cann Pharmaceutical Australia to develop a new treatment for the 50,000 Australians living with melanoma.

Professor Sudha Rao will lead the two-year research project which aims to create an immunotherapy treatment to complement traditional chemotherapy. Photo: Supplied

The two-year research project, led by molecular and cellular biologist Professor Sudha Rao, will examine how cannabis can be used in combination with radiation and other therapies to treat cancer.

Cann Pharmaceutical Australia’s managing director Andrew McCrea said the first results of the clinical trials could be known as soon as next year.

Medical grade cannabis will be trialled alongside chemotherapy as a new treatment for melanoma.  Photo:

... read more at: